MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$97K
Net Income
-$3,007K
Net Profit Margin
-3100.00%
EPS
-$3.51
Unit: Thousand (K) dollars
Revenue Breakdown
    • General and administrative
    • Research and development-Researc...
    • Other segment items
    • Research and development-Repibre...

Income Statement
2026-06-30
Total revenues
97
Research and development
788
General and administrative
2,411
Total operating expenses
3,199
Operating loss
-3,102
Other income, net
203
Loss from continuing operations before income taxes
-2,899
Income tax expense
0
Loss from continuing operations
-2,899
Loss from discontinued operations, net of income taxes
-108
Net loss
-3,007
Unrealized losses on marketable securities, net of tax of 0
0
Total other comprehensive loss
0
Comprehensive loss
-3,007
Basic EPS
-3.51
Diluted EPS
-3.51
Basic Average Shares
858,000
Diluted Average Shares
858,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$3,007K Net loss-$3,007K Loss from continuingoperations-$2,899K Loss fromdiscontinued operations, net...-$108K General andadministrative$2,411K Research anddevelopment-Research And Development...$398K Other segment items$348K Research anddevelopment-Repibresib VYN201$42K Loss from continuingoperations before income...-$2,899K Other income, net$203K Total operatingexpenses$3,199K Operating loss-$3,102K Total revenues$97K Operating loss-$3,102K Total operatingexpenses$3,199K General andadministrative$2,411K Research and development$788K

Yarrow Bioscience, Inc. (YARW)

Yarrow Bioscience, Inc. (YARW)